The Federal Trade Commission has filed an amicus brief in Takeda Pharmaceutical Co. v Zydus Pharmaceuticals (USA) Inc., which is a patent infringement case pending before the U.S. District Court for the District of New Jersey. The 1984 Hatch-Waxman Act established a regulatory framework for promoting generic drug competition. The law permits the brand and […]